SCHEMBL29856274

SCHEMBL29856274

Cn1c(C2CC2)c(C(=O)c2ccc(O)cc2)c2ccncc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 7/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
HIPK2 Q9H2X6 1/20 0.35
ELANE P08246 1/20 0.34
MAPT P10636 2/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
ATM Q13315 1/20 0.33
CYP19A1 P11511 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856309 0.84 SLC22A12 (0.39) ROCK2ADORA3ADORA2AHIPK2ELANE
SCHEMBL29856218 0.84 SLC22A12 (0.44) ROCK2ADORA3ADORA2AHIPK2ELANE
SCHEMBL29856503 0.82 ADORA3 (0.44) ROCK2ADORA3ADORA2AMAPTESR1
SCHEMBL29856201 0.82 ELANE (0.43) ROCK2ADORA3ADORA2AHIPK2ELANE
SCHEMBL29856150 0.80 SLC22A12 (0.42) ROCK2ADORA3ADORA2AELANE
SCHEMBL29856491 0.80 SLC22A12 (0.38) ROCK2ADORA3ADORA2A
SCHEMBL29856329 0.79 ELANE (0.41) ROCK2ADORA3ADORA2AHIPK2ELANE
SCHEMBL29856340 0.78 ROCK2 (0.38) ROCK2ADORA3ADORA2AELANEMAPT
SCHEMBL29856214 0.78 KDM5A (0.40) ROCK2ADORA3ADORA2AMAPTESR1
SCHEMBL29856230 0.78 ROCK2 (0.42) ROCK2ADORA3ADORA2AMAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed